07 May 2008 - GeneNews Limited announced its shareholders recently elected two additional members to its Board of Directors, Mr. Harry A. Glorikian and Ms. Fran Tuttle. They join Mr. Rory Riggs, Mr. James Howard-Tripp, Mr. Garth MacRae, Dr. Heiner Dreismann, Dr. C. C. Liew and Dr. K. Wayne Marshall on the Company's Board of Directors.
Prior to becoming the Managing Partner at Scientia Advisors, Mr. Glorikian spent more than 8 years at Applied Biosystems in various roles, completing his tenure as Senior Manager, New Technology Assessment/Business Development. He was also the National Sales Manager for Signet Laboratories and a founder of X-Cell Laboratories, a clinical reference laboratory in San Francisco.
Ms. Tuttle is currently the President and CEO of HX Diagnostics. Throughout her career, she has developed and launched several major diagnostics products and had corporate experience at leading diagnostic companies including Bayer, Corning, Inc., Novartis, and Chiron. Ms. Tuttle was a Senior Vice President at Bayer Diagnostics responsible for a worldwide business of $400M. Most recently Ms. Tuttle was President and CEO of Protedyne, Inc., a robotics company developing automation solutions for molecular diagnostics and drug discovery, which was sold to LabCorp in 2007.
 |
www.bionity.com/news/e/81765 |
|
 |
|
|
© Chemie.DE Information Service GmbH http://www.bionity.com/news/e/81765 |
Seydelstr. 28 · 10117 Berlin info@chemie.de · Tel: +49 (0)30 20 45 68 - 0 |